U.S. District Court issues decision in NPWT patent litigation

The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. (NYSE:KCI), Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid. KCI will continue to analyze the Court's ruling and assess its next steps including, among other options, a request for reconsideration or an appeal to the Court of Appeals for the Federal Circuit. This ruling does not affect any other patents in KCI's extensive negative pressure intellectual property portfolio.

“We have successfully competed for years against other NPWT products. This decision will not change the fact that we offer the most proven and innovative NPWT solutions in the marketplace, backed by the vast majority of clinical evidence and the broadest clinical expertise and field service in the industry.”

"We strongly disagree with the Court's decision, which effectively sets aside the jury verdict from March 2010," said Cathy Burzik, KCI president and CEO. "We have successfully competed for years against other NPWT products. This decision will not change the fact that we offer the most proven and innovative NPWT solutions in the marketplace, backed by the vast majority of clinical evidence and the broadest clinical expertise and field service in the industry."

Source:

Kinetic Concepts

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.